Mutant HER2 needs mutant HER3 to be an effective oncogene

Trenker, R; Diwanji, D; Jura, N

Jura, N (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.; Jura, N (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.

CELL REPORTS MEDICINE, 2021; 2 (8):

Abstract

Hanker et al. reveal that co-occurring missense mutations in the human epidermal growth factor receptor 2 (HER2) and its catalytically inactive homolo......

Full Text Link